Jefferies Cuts Price Target on Gilead Sciences (GILD), Notes Positive Quad Feedback From HIV Survey
Go back to Jefferies Cuts Price Target on Gilead Sciences (GILD), Notes Positive Quad Feedback From HIV Survey| Gilead Sciences (NASDAQ: GILD) | Delayed: 138.92 +0.56 (0.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $138.36 | 52 Week High | $108.63 | |||
| Open | $138.36 | 52 Week Low | $71.39 | |||
| Day High | $139.49 | P/E | 76.75 | |||
| Day Low | $136.63 | EPS | $1.81 | |||
| Volume | 3,940,360 | |||||
